Catalytic asymmetric total synthesis of (+)-lactacystin

Journal of Organic Chemistry

Volumn 71, Issue 3, 2006, Pages 1220-1225

  Fukuda, Nobuhisa ^a   Sasaki, Kazuki ^a   Sastry, T V R S ^a   Kanai, Motomu ^a   Shibasaki, Masakatsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; GLUCOSE; MOLECULAR STRUCTURE; OPTIMIZATION; SYNTHESIS (CHEMICAL);

C-5 CARBON; CATALYTIC ENANTIOSELECTIVE STRECKER; ENANTIOSELECTIVITY; ENONE-DERIVED N-PHOSPHINOYL KETOIMINE 7; LACTACYSTIN; PROTEASOME INHIBITOR;

ORGANIC ACIDS;

GADOLINIUM; HYDROXYL GROUP; KETOIMINE; LACTACYSTIN; LACTACYSTIN BETA LACTONE; METHYL GROUP; NICKEL; PROTEASOME INHIBITOR; SILICON DERIVATIVE; UNCLASSIFIED DRUG;

ADDITION REACTION; ARTICLE; ASYMMETRIC CATALYSIS; ASYMMETRIC SYNTHESIS; CHELATION; CHIRALITY; CONJUGATION; DONOHOE METHYLATION; ENANTIOMER; ENANTIOSELECTIVITY; METHYLATION; MOLECULAR STABILITY; NONHUMAN; OXIDATION; REACTION OPTIMIZATION; REDUCTION KINETICS; STEREOCHEMISTRY; SUBSTITUTION REACTION; TAMAO OXIDATION;

ACETYLCYSTEINE; CATALYSIS; IMINES; LACTONES; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 32144447583     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0524223     Document Type: Article

References (61)

1. Omura, S.; Fujimoto, T.; Otoguro, K.; Matsuzaki, K.; Moriguchi, R.; Tanaka, H.; Sasaki, Y. J. Antibiot. 1991, 44, 113-116.
2. Fenteany, G.; Standaert, R. F.; Lane, W. S.; Choi, S.; Corey, E. J.; Schreiber, S. L. Science 1995, 268, 726-731.
3. Groll, M.; Ditzel, L.; Löwe, J.; Stock, D.; Bochtler, M.; Bartunik, H. D.; Huber, R. Nature 1997, 386, 463-471.
4. (a) Dick, L. R.; Cruikshank, A. A.; Greiner, L.; Melandri, F. D.; Nunes, S. L.; Palombella, V. J.; Parent, L. A.; Plamondon, L.; Stein, R. L. J. Biol. Chem. 1997, 272, 182-188.
5. (b) Dick, L. R.; Cruikshank, A. A.; Destree, A. T.; Greiner, L.; McCormack, T. A.; Melandri, F. D.; Nunes, S. L.; Stein, R. L. J. Biol. Chem. 1996, 271, 7273-7276.
6. For a review, see: Zavrski, I.; Jakob, C.; Schmid, P.; Krebbel, H.; Kaiser, M.; Fleissner, C.; Rosche, M.; Possinger, K.; Sezer, O. Anti-Cancer Drugs 2005, 16, 475-481.
7. (a) Corey, E. J.; Reichard, G. A. J. Am. Chem. Soc. 1992, 114, 10677-10678.
8. (b) Corey, E. J.; Li, W.; Reichard, G. A. J. Am. Chem. Soc. 1998, 120, 2330-2336.
9. (c) Saravanan, P.; Corey, E. J. J. Org. Chem. 2003, 68, 2760-2764.
10. (d) Reddy, L. R.; Fournier, J. R.; Reddy, B. V. S.; Corey, E. J. J. Am. Chem. Soc. 2005, 127, 8974-8976.
11. (e) Reddy, L. R.; Saravanan, P.; Fournier, J.-F.; Reddy, B. V. S.; Corey, E. J. Org. Lett. 2005, 7, 2703-2705.
12. (f) Sunazuka, T.; Nagamitsu, T.; Matsuzaki, K.; Tanaka, H.; Omura, S.; Smith, A. B., III. J. Am. Chem. Soc. 1993, 115, 5302.
13. (g) Nagamitsu, T.; Sunazuka, T.; Tanaka, H.; Omura, S.; Sprengeler, P. A.; Smith, A. B., III. J. Am. Chem. Soc. 1996, 118, 3584-3590.
14. (h) Uno, H.; Baldwin, J. E.; Russell, A. J. Am. Chem. Soc. 1994, 116, 2139-2140.
15. (i) Chida, N.; Takeoka, J.; Tsutsumi, N.; Ogawa, S. J. Chem. Soc., Chem. Commun. 1995, 793-794.
16. (j) Kang, S. H.; Jun, H.-S. Chem. Commun. 1998, 1929-1930.
17. (k) Soucy, F.; Grenier, L.; Behnke, M. L.; Destree, A. T.; McCormack, T. A.; Adams, J.; Plamondon, L. J. Am. Chem. Soc. 1999, 121, 9967-9976.
18. (l) Panek, J. S.; Masse, C. E. Angew. Chem., Int. Ed. 1999, 38, 1093-1095.
19. (m) Ooi, H.; Ishibashi, N.; Iwabuchi, Y.; Ishihara, J.; Hatakeyama. S. J. Org. Chem. 2004, 69, 7765-7768.
20. (n) Donohoe, T. J.; Sintim, H. O.; Sisangia, L.; Marling, J. D. Angew. Chem., Int. Ed. 2004, 43, 2293-2296.
21. (o) Donohoe, T. J.; Sintim, H. O.; Sisangia, L.; Ace, K. W.; Guyo, P. M.; Cowley, A.; Marling, J. D. Chem.-Eur. J. 2005. 11, 4227-4238.
22. (p) Iwama, S.; Gao, W.-G.; Shinada, T.; Ohfune, Y. Synlett 2000, 1631-1633.
23. (q) Green, M.; Prodger, J. C.; Hayes, C. J. Tetrahedron Lett. 2002, 43, 6609-6611.
24. (r) Brennan, C. J.; Pattenden, G.; Rescourio, G. Tetrahedron Lett. 2003, 44, 8757-8760.
25. (s) Wardrop, D. J.; Bowen, E. G. Chem. Commun. 2005, 5106-5108.
26. For reviews, see: (t) Corey, E. J.; Li, W. Z. Chem. Pharm. Bull. 1999. 47, 1-10.
27. (u) Masse, C. E.; Morgan, A. J.; Adams, J.; Panek, J. S. Eur. J. Org. Chem. 2000, 2513-2528.
28. For the total synthesis of TMC-95A, see: (a) Inoue, M.; Sakazaki, H.; Furuyama, H.; Hirama, M. Angew. Chem., Int. Ed. 2003, 42, 2654-2657.
29. (b) Lin, S.; Yang, Z.-Q.; Kwok, B. H. B.; Koldobskiy, M.; Crews, C. M.; Danishefsky, S. J. J. Am. Chem. Soc. 2004, 126, 6347-6355.
30. (c) Albrecht, B. K.; Williams, R. M. Org. Lett. 2003, 5, 197-200.
31. For the total synthesis of epoxomicin. see: (d) Katukojvala, S.; Barlett, K. N.; Lotesta, S. D.; Williams, L. J. J. Am. Chem. Soc. 2004, 126, 15348-15349.
32. (e) Sin, N.; Kim, K. B.; Elofsson, M.; Meng, L.; Auth, H.; Kwok, B. H. B.; Crews, C. M. Bioorg. Med. Chem. Lett. 1999, 9, 2283-2288.
33. For the total synthesis of salinosporamide A. see: (f) Reddy, L. R.; Saravanan, P.; Corey, E. J. J. Am. Chem. Soc. 2004, 126, 6230-6231.
34. (g) Endo, A.; Danishefsky, S. J. J. Am. Chem. Soc. 2005, 127, 8298-8299.
35. Gao, Y.; Hanson, R.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765-5780.
36. Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Jeong, K.-S.; Kwong, H.-L.; Morikawa, K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768-2771.
37. Li, G.; Angert, H. A.; Sharpless, K. B. Angew. Chem., Int. Ed. Engl. 1996, 35, 2837-2841.
38. Seebach, D.; Aebi, J. D. Tetrahedron Lett. 1983, 24, 3311-3314.
39. (a) Masumoto, S.; Usuda, H.; Suzuki, M.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2003, 125, 5634-5635.
40. (b) Kato, N.; Suzuki, M.; Kanai, M.; Shibasaki, M. Tetrahedron Lett. 2004, 45, 3147-3151.
41. (c) Kato, N.; Suzuki, M.; Kanai, M.; Shibasaki, M. Tetrahedron Lett. 2004, 45, 3153-3155.
42. For catalytic enantioselective Strecker reactions developed by other aroups, see: (a) Vachal, P.; Jacobsen, E. N. Org. Lett. 2000, 2, 867-870.
43. (b) Vachal, P.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 10012-10014.
44. (c) Chavarot, M.; Byrne, J. J.; Chavant, P. Y.; Vallée, Y. Tetrahedron: Asymmetry 2001, 12, 1147-1150.
45. For recent examples of the synthesis of β-hydroxy carbonyl compounds using this method, see: (a) Trost, B. M.; Ball, Z. T. J. Am. Chem. Soc. 2004, 126, 13942-13944.
46. (b) Barrett, A. G. M.; Head, J.; Smith, M. L.; Stock, N. S.; White, A. J. P.; Williams, D. J. J. Org. Chem. 1999, 64, 6005-6018.
47. (c) Usuda, H.; Kanai, M.; Shibasaki, M. Org. Lett. 2002, 4, 859-862.
48. (d) Usuda, H.; Kanai, M.; Shibasaki, M. Tetrahedron Lett. 2002, 43, 3621-3624.
49. Compound 7 can be used as a masked α-hydroxy ketoimine equivalent. α-Hydroxy phosphinoylketoimines such as A or B were unstable, and we could not synthesize these compounds in a pure form. For the synthesis of 7, see Supporting Information for details. (Equation presented).
50. Yabu, K.; Masumoto, S.; Yamasaki, S.; Hamashima, Y.; Kanai, M.; Du, W.; Curran, D. P.; Shibasaki, M. J. Am. Chem. Soc. 2001, 123, 9908-9909.
51. Bajgrowicz, J. A.; Berg-Schultz, K.; Brunner, G. Bioorg. Med. Chem. 2003. 11, 2931-2946.
52. Krzyzanowska, B.; Stec, W. J. Synthesis 1982, 270-271.
53. 3, or HCN-EtOH) did not proceed well (<20% yield). The chiral Gd-8 complex generally produces significantly higher activity than that of strongly Lewis acidic achiral promoters.
54. The use of HCN instead of 2,6-dimethylphenol did not improve the catalyst activity and enantioselectivity in this case.
55. 3 in cyanosilylation of a reactive ketone is shown in the following scheme. (Equation presented).
56. 13C NMR chemical shifts of 2 with the reported values.
57. (a) Ager, D. J.; Fleming, I.; Patel, S. K. J. Chem. Soc., Perkin Trans. 1 1981, 2520-2526.
58. (b) Fleming, I.; Rowley, M.; Cuadrado, P.; González-Nogal, A. M.; Pulido, F. J. Tetrahedron 1989, 45, 413-424.
59. Jones, G. R.; Landais, Y. Tetrahedron 1996, 52, 7599-7662.
60. Crump, R. A. N. C.; Fleming, I.; Urch, C. J. J. Chem. Soc., Perkin Trans, 1 1994, 701-706.
61. 2Si group could be introduced to 4 with excellent stereoselectivity and yield. The Tamao oxidation, however, did not proceed from this silylated product.